A recombinant baculovirus harboring the hemagglutinin (HA) gene of African swine fever virus, with homology to the Tlymphocyte surface antigen CD2, was constructed. The efficient expression of the HA gene was determined by immunofluorescence and Western blot studies on insect cells infected with the recombinant baculovirus. The baculovirus-expressed HA showed hemadsorption and erythrocyte-agglutinating activities characteristic of the CD2 homolog protein induced by the virus in infected macrophages. Pigs immunized with the recombinant HA developed hemagglutination-inhibition and temporary infection-inhibition antibodies that recognize a 75-kDa structural protein and were protected against lethal infection. ᭧
African swine fever virus (ASFV), the causative agent of
Recently the complete nucleotide sequence of the ASFV genome (11, 12) has been reported. Database comAfrican swine fever, is an icosahedral cytoplasmic deoxivirus that infects porcine species. The infection of domestic parisons have provided clues about genes that could modulate virus-host interactions. One of them is a gene pigs with virulent ASFV strains leads to a highly lethal disease. Pigs surviving infection with attenuated variants of with sequence similarities to the adhesion receptor of T cells, CD2. This protein is directly involved in the hem-ASFV develop resistance to infection with homologous virulent viruses (1, 2) . Sera from these pigs were capable of adsorption phenomenon induced by the infection of susceptible cells with the ASFV (13, 14) . DNA amplification inhibiting the virus replication in pig buffy coat cultures (3) (4) (5) . Furthermore, in passive transfer experiments in swine, of the CD2-like gene from the Spanish attenuated isolate E75CV 1 was carried out by PCR using AmpliTaq DNA these anti-ASFV antibodies have been shown to play a role in protective immunity to a homologous virulent ASFV (6).
polymerase (Perkin-Elmer Cetus) with the following primers: (i) 5-GCGCGGATCCATGATAATAATAGTTATT The proposed humoral immune mechanisms responsible for this protection are not conclusive and the identities of (5 primer), which includes the recognition sequence for viral antigens responsible of inducing the protective rethe BamHI restriction enzyme, and (ii) 5-GCGCGAATTsponse are unknown (7, 8) .
CTTAAATAATTCTATCTAC (3 primer), which contains One of the most interesting characteristics of ASFV the recognition sequence for the EcoRI restriction eninfection is the induction of hemadsorption of pig erythrozyme. The DNA template was obtained from supernacytes to the infected cell surface (9) . We have previously tants of infected CV 1 cell cultures (15). The PCR product described a virus-induced glycoprotein in ASFV-infected was digested with EcoRI and BamHI and cloned into cells, the hemagglutinin (HA), which produces in vitro Pak 8 transfer vector under the control of the polyhedrin hemagglutination of pig erythrocytes in the absence of promoter of baculovirus (Clontech), which had been pre-ASFV particles (10) . In preliminary experiments pigs imviously digested with the same enzymes. The cloned munized with nonpurified HA showed some resistance gene was sequenced by the dideoxynucleotide chain to the homologous virulent strains (10) . However, assesstermination method with specific primers, showing 100% ment of the relevance of the immune response to HA similarity with the gene encoded by BA71V virus preglycoprotein in protection is necessary to obtain this proviously sequenced (12) . Both viruses, E75 and BA71, tein free of other ASFV components. Therefore, we were isolated in Spain within a few years of each other thought to produce the HA glycoprotein of ASFV using and they are probably closely related. the baculovirus expression system. Then, a recombinant baculovirus expressing the ASFV HA was constructed. Briefly, Sf cells were transfected with a mixture of the transfer recombinant vector induced by HABv in infected cells, but not in the wildtype baculovirus-infected cells.
To confirm that the ASFV CD2-like protein, responsible for hemadsorption, and the ASFV HA glycoprotein are the same antigen, different assays were carried out. Hemadsorption tests were performed in monolayers of Sf cells in 35-mm dishes. The cells were infected with either the recombinant or wild-type baculovirus at a m.o.i. of 0.5 and incubated at 28Њ for 24 hr. At this time, the culture medium was removed and 3 ml of fresh medium mixed with 20 ml of a 20% suspension of swine erythrocytes was added to each dish. Rosette formation was scored 3 hr later. and secreted HA showed that most of the HA produced by the recombinant baculovirus is associated to the cellular fraction (40 times more hemagglutination activity Bsu36I digest, which contains the b-galactosidase gene under the control of the polyhedrin promoter of baculovidetected in the cellular fraction than found in the supernatant). The comparative analysis of HA production in rus (Clontech). After 4 days incubation at 28Њ, supernatants were tested for plaque formation in Sf monolayers.
insect cells infected at a m.o.i. of 1 with the recombinant baculovirus at different hours postinfection showed a Plaques were recovered and then purified by three consecutive plaque assays in Sf cell monolayers. Selection maximum of the recombinant HA induction at 72 hr after infection, decreasing 24 hr later (data not shown). Control of recombinant plaques was made by color selection. . Fifteen days after last inoculation, the pigs lovirus was also examined by Western blot analysis of infected cell extracts (Fig. 1) . The anti-ASFV serum dewere bled for serum. All immunized pigs with the recombinant baculovirus tected a protein with a molecular weight of about 75 kDa developed specific antibodies against the HA as demon-18). The low amounts of this protein in the particle, as well as the absence or low quantity of specific antibodies strated by immunofluorescence experiments. Sera from immunized pigs stained by immunofluorescence permeagainst HA in most sera from ASFV-infected pigs could explain the difficulties in the detection of this antigen in abilized Vero cells infected with the ASFV isolate 1207VR11. As shown in Figs. 2a and 2b , most of the HA the viral particle by different authors. This is exemplified by the serum anti-1207VR11 virus, which showed hemagdetected is located at 12 hr p.i. in the cytoplasm of the infected cells, giving a characteristic corpuscular immuglutination-inhibition antibodies but did not detect the HA in the viral particle, while this serum detected the nofluorescence, corresponding to the viral factories where viral morphogenesis takes place. Interestingly, in recombinant HA overexpressed in insect cells (Fig. 1) . However, after hyperimmunization with the recombinant a time course experiment of immunofluorescence, the HA was first detected at 12 hr after infection, simultane-HA, pigs developed enough antibodies to recognize the HA in the viral particle in a Western blot (Fig. 1 ). These ously with the first images of hemadsorption of pig erythrocytes shown in parallel cultures (data not shown).
data indicate that the HA protein is a minority component of the viral particle that is detectable only by using sera To explore the possibility that the ASFV HA was a structural protein, extracellular BA71V ASFV particles with a high antibody titer against this protein.
The biological relevance of this finding could be of were purified from infected Vero cell supernatants by Percoll equilibrium centrifugation as described elseimportance in the transportation of the virus associated to the erythrocytes (more than 90%) during in vivo infecwhere (16) . Then, the purified virus was analyzed by Western blot using the anti-HA antibodies generated in tion (19, 20, 21) . Electron microscope studies (22) indicated that after attachment, the virion does not penetrate the immunized pigs (a pool of the three sera from pigs 1, 2, and 3). Antibodies from pigs reacted with purified the erythrocyte, but remains connected to the outside surface via a tunnel. The HA could mediate this attachextracellular particles, recognizing a viral protein of 75 kDa (Fig. 1) , with the same electrophoretic mobility as ment, and in this manner, virions could evade the immune system, explaining the long viremia periods shown that previously described for the recombinant HA. The presence of glycoproteins in the ASFV particle has been in survival pigs after infection with ASFV. Anti-hemagglutinating antibody titers and the infectiondiscussed by several authors with different results (17, hibiting the cytopathic effect produced by the virus in vitro, as previously described for sera from convalescent pigs (3). However, all pigs immunized with the recombinant HA developed the same titers of anti-hemagglutinin antibodies. In spite of the fact that antibodies that inhibit infection could play an important role in protection, pigs 2 and 3 in absence of these kinds of antibodies resist the challenge exposure to a virus that kills 100% of inoculated pigs. This seems to indicate that other antibodymediated mechanisms may contribute to the resistance against the disease and HA seems to be the target of these partially protective antibodies.
It has been reported that in ASFV infection, after vire- showed, in a 5-day assay, infection-inhibition indexes of 2.66, while the infection-inhibition index from pig 1 (in which viremia was not detectable) remained constant at inhibition index of immune sera were measured as described (10) . Hemagglutination-inhibition assays were the same days (1.16).
The data presented here clearly demonstrate that the carried out with 8 HA units from both recombinants or infected Vero cells obtained HA (infected with 1207VR11 hemagglutinin of ASFV is expressed functionally in a baculovirus system. On the other hand, to our knowledge, virus strain). Maximum titers of 1/80 for both antigens were obtained from monospecific sera obtained from this is the first report of protection against ASFV by using a recombinant virus protein. This protection was similar pigs immunized with the recombinant protein. These results suggest that both antigens were functionally simito that obtained in passive antibody transfer experiments using immunoglobulins purified from convalescent pigs lar. Interestingly, only pig 1 inoculated with more HA doses showed a temporary (5 days) infection-inhibition (6). The different immune response observed between pig 1, immunized with highest doses of antigen, and pigs index of 1.67 (titer of ASFV grown in presence of preimmune serum minus titer of ASFV grown in presence of 2 and 3 suggests that protection could be conferred in a dose-dependent response to HA. Unfortunately, the immune serum), determined by cytopathic effect in pig buffy coat cultures. These results seem to indicate that ASFV HA is not very antigenic (10) , and it will probably be necessary to inoculate higher doses of the recombinant in the ASFV HA the epitopes responsible for inducing infection inhibition and hemagglutination inhibition could protein to confer better protection against ASFV infection or improve the antigenic presentation of this antigen to be different.
To explore the possibility of protective immunity to the immune system. Experiments in this direction are being pursued. ASFV conferred by the HA, all immunized and control pigs were challenged intramusculary with 4 1 10 2 tissue culture infectious dose 50 (TCID 50 ) of the virulent strain ACKNOWLEDGMENTS of ASFV E75. The viremia titers of the different challenged pigs, estimated in blood samples obtained with intervals
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blood (3) . Control pigs (pigs 4, 5, and 6) died between Postinfection Days 7-8 and the titers of viremia at Day 6 were from 10 6.69 to 10 7.02 . In contrast, all pigs inoculated
